A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs - Netherlands
doi 10.1007/s10637-014-0173-7
Full Text
Open PDFAbstract
Available in full text
Date
October 18, 2014
Authors
Publisher
Springer Science and Business Media LLC